What are the current NICE guidelines for managing a patient with bilateral superior nasal visual field defects, intraocular pressure of 19‑20 mmHg, and cataract?

Management Recommendation

Treat as glaucoma suspect with IOP-lowering therapy and proceed with cataract surgery when visual symptoms warrant, as cataract surgery alone may lower IOP and improve glaucoma management. 1, 2

Clinical Reasoning

Glaucoma Assessment (IOP 19-20 mmHg with VF Defects)

Your patient presents with bilateral superior nasal visual field defects and borderline-elevated IOP (19-20 mmHg), which represents glaucomatous damage requiring treatment. While IOP is not dramatically elevated, the presence of documented VF defects indicates the disease is already causing optic nerve damage 1.

Key management principles:

• IOP reduction is the only modifiable risk factor and has been proven in clinical trials to slow glaucoma progression 1
• Establish a target IOP range based on the severity of existing damage (moderate given the VF defects present)
• The goal is preventing further visual field and optic nerve/RNFL deterioration to preserve quality of life 1

Cataract Surgery Timing Considerations

Cataract surgery should be performed when it will enhance patient function AND when indicated for improved visualization and management of coexisting ocular disease such as glaucoma 2. This is particularly relevant in your case because:

• Cataract may be obscuring adequate visualization of the optic nerve for glaucoma monitoring
• Cataract surgery alone typically lowers IOP by 1-4 mmHg, which may help achieve target IOP
• The visual symptoms from cataract combined with VF defects from glaucoma compound functional impairment

Integrated Management Algorithm

Step 1: Initiate IOP-lowering therapy immediately

• Begin topical prostaglandin analog (first-line for POAG) 1
• Establish baseline imaging: central corneal thickness, optic nerve head/RNFL imaging, and macular assessment 1

Step 2: Assess cataract impact on function

• If cataract significantly impairs vision or prevents adequate glaucoma monitoring → proceed with surgery 2
• If cataract is mild and not functionally limiting → optimize medical glaucoma management first

Step 3: Coordinate surgical approach

• Consider combined cataract-glaucoma surgery if IOP remains uncontrolled on maximum tolerated medical therapy
• Standalone cataract surgery is appropriate if IOP is controlled or borderline, as phacoemulsification alone provides IOP reduction 2

Critical Pitfalls to Avoid

• Do not delay cataract surgery indefinitely waiting for "perfect" glaucoma control—the surgery itself aids IOP management 2
• Do not attribute all VF defects to cataract alone—your patient has true glaucomatous damage requiring ongoing monitoring 1
• Ensure adequate postoperative IOP monitoring as cataract surgery can cause temporary IOP elevation requiring treatment 2

Follow-up Protocol

After initiating treatment, assess adequacy through:

• Regular optic nerve appearance evaluation
• Quantitative visual field testing
• Optic nerve head, RNFL, and macular imaging 1

The timing between assessments depends on disease severity and IOP control, but typically every 3-6 months initially.